Rakuten Medical News and Activities

Rakuten Medical is owned by Rakuten.

Rakuten is one of the...

• Forbes Global 2000 (#1035);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Rakuten is a company listed under the stock ticker 4755 (JP).

Rakuten has a direct presence in 8 countries.

Rakuten has 18 subsidiaries including Cartera Commerce, Kobo and Rakuten Advertising.

They are in:

• Retail37%
• Telecommunications16%
• Other47%

Acquisition, funding and merger involving Rakuten.

• Rakuten Medical has just announced a $100 Million fundraising (posted on January 8 2026).

View the org chart displaying its 27 main executives

Most searched biographies at Rakuten Medical

• Minami Maeda, Chief Executive Officer
• Nitin Nohria, Chairman of the Board
• Kentaro Hyakuno, Director

Popular executive movements at Rakuten Medical

• Hiroshi Mikitani who is Chief Executive Officer and Chairman of the Board, will become Chairman of the Board on Jul. 1, 2026  (posted on June 11 2026).
• Minami Maeda who is President and Managing Director of Taiwan, will become Chief Executive Officer on Jul. 1, 2026  (posted on June 11 2026).

Create your alert
to follow the executive moves at Rakuten Medical.

Rakuten has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Rakuten Medical

• Commencement of Investigator-Initiated Trial (IIT) of Photoimmunotherapy in Gynecologic Cancers in Japan - Rakuten Medical - To conquer cancer.
• Rakuten Medical Announces Commercialization of Medical Devices “BioBlade™ Laser WR” and “BioBlade SideFire Diffuser ™” in Japan for Photoimmunotherapy for Head and Neck Cancer based upon its Alluminox Platform - Rakuten Medical - To conquer cancer.
• Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024 - Rakuten Medical - To conquer cancer.
• Rakuten Medical Announces New Management Team to Drive the Next Phase of Growth and Innovation - Rakuten Medical - To conquer cancer.
• Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting - Rakuten Medical - To conquer cancer.
• Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024 - Rakuten Medical - To c
• Rakuten Medical’s Poster Presentation at AACR 2024 Demonstrates Reduction in Photoimmunotherapy-induced Edema in Mice with COX-2 Inhibition - Rakuten Medical - To conquer cancer.
• Rakuten Medical’s Upcoming Poster Presentation at AACR 2024: New Findings in Mouse Study to Manage Edema Associated with Photoimmunotherapy based on the Alluminox™ Platform - Rakuten Medical - To conquer cancer.
• Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform - Rakuten Medical - To conquer cancer.
• Over 20 Presentations on Alluminox Treatment (Photoimmunotherapy) at International Conferences in 2023 - Rakuten Medical - To conquer cancer.
• View more press releases Close

Social media about Rakuten Medical

• Rakuten Medical on Wikipedia, Google News & Yahoo Finance
• Rakuten Medical on LinkedIn, X (Twitter) & YouTube